Glycaemic Variability and Hyperglycaemia as Prognostic Markers of Major Cardiovascular Events in Diabetic Patients Hospitalised in Cardiology Intensive Care Unit for Acute Heart Failure

Autor: Edouard Gerbaud, Ambroise Bouchard de La Poterie, Thomas Baudinet, Michel Montaudon, Marie-Christine Beauvieux, Anne-Iris Lemaître, Laura Cetran, Benjamin Seguy, François Picard, Fritz-Line Vélayoudom, Alexandre Ouattara, Rémi Kabore, Pierre Coste, Pierre Domingues-Dos-Santos, Bogdan Catargi

Publikováno v: Journal of Clinical Medicine
Journal of Clinical Medicine, 2022, 11 (6), ⟨10.3390/jcm11061549⟩
Journal of Clinical Medicine; Volume 11; Issue 6; Pages: 1549
Journal of Clinical Medicine, MDPI, 2022, 11 (6), ⟨10.3390/jcm11061549⟩

(1) Background: Hyperglycaemia and hypoglycaemia are both emerging risk factors for cardiovascular disease. Nevertheless, the potential effect of glycaemic variability (GV) on mid-term major cardiovascular events (MACE) in diabetic patients presentin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d9f47714f8879460ebc4d03673d9688
https://hal.science/hal-03634108